haloperidol has been researched along with Cerebrovascular Moyamoya Disease in 1 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinboshi, M | 1 |
| Inoue, M | 1 |
| Kojima, Y | 1 |
| Nakagawa, T | 1 |
| Kanda, M | 1 |
| Shibasaki, H | 1 |
1 other study available for haloperidol and Cerebrovascular Moyamoya Disease
| Article | Year |
|---|---|
[Elderly case of moyamoya disease presenting with hemichorea].
Topics: Chorea; Dopamine Antagonists; Female; Haloperidol; Humans; Magnetic Resonance Imaging; Middle Aged; | 2012 |